Press Releases
Apr. 7, 2026
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA
Indeterminate
GlobeNewswire, Inc.
Apr. 9, 2026
Europe Moves to Restrict Social Media Access for Minors
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Apr. 9, 2026
CHERRY XTRFY Launches New Compact Magnetic Switch Keyboard with TMR Technology
Indeterminate
GlobeNewswire, Inc.
Mar. 25, 2026
GAAPP Expands International Leadership Team to Drive Global Patient-Centered Research and Advocacy
Neutral
EIN Presswire
Mar. 19, 2026
PIUR IMAGING Launches AI-Powered Software Reducing Thyroid Ultrasound Workflow Time by up to 60%
Neutral
EIN Presswire
Mar. 26, 2026
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
Indeterminate
GlobeNewswire, Inc.
Apr. 2, 2026
Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030 | MarketsandMarkets™
Indeterminate
GlobeNewswire, Inc.
Mar. 25, 2026
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
Indeterminate
GlobeNewswire, Inc.
Apr. 2, 2026
NCDA&CS Agronomic Services Division releases new guide to help growers maximize nutrient value of cover crops
Gov't Institution
North Carolina Department of Agriculture & Consumer Services
Owner: American Government
Mar. 24, 2026
Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering
Indeterminate
GlobeNewswire, Inc.
Mar. 23, 2026
Outlook Therapeutics Announces Proposed Public Offering
Indeterminate
GlobeNewswire, Inc.
Apr. 8, 2026
President Cyril Ramaphosa: Presentation of Letters of Credence of new Heads of Mission accredited to South Africa
Gov't Institution
South African Government
Owner: South African Government
Apr. 7, 2026
Rover Reveals How Americans Are Redefining Pet Parenthood Across Generations
Indeterminate
GlobeNewswire, Inc.
Apr. 7, 2026
Russia’s Foreign Ministry Denounces US-Israeli Attacks on Iran
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 25, 2026
TOMI Environmental Solutions’ Binary Ionization Technology Approved in the Netherlands
Indeterminate
GlobeNewswire, Inc.
Mar. 16, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note
Indeterminate
GlobeNewswire, Inc.
Mar. 18, 2026
De La Rosa 613 Taryag Grüner Veltliner Wins Top Honors in The Jewish Link’s Annual Kosher Wine Guide
Neutral
EIN Presswire